Blood Test

Compared with usual care, a mid-trimester blood test designed to predict preterm birth for average-risk women markedly reduced neonatal morbidity when paired with a three-step treatment bundle, researchers reported at The Pregnancy Meeting.

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and subsequently for assisting clinicians in formulating a treatment plan for patients, according to new research.

Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its severity, according to a study published in The Journal of Clinical Investigation.

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.

Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its derivative free carnitine, which may enable blood-based biomarker detection of the disease, according to a study.

WISDOM, a research study comparing annual mammography with a personalized approach to screening based on individual risk factors, is currently underway and enrolling women in the U.S. aged 30 to 74 years without a history of breast cancer.

A novel evaluation of biomarkers known to be associated with pancreatic cancer significantly improved detection of early-stage disease compared with previous tests, according to results of a double-blind phase 2 trial.

Both colonoscopies and stool-based tests for colorectal cancer screening may be more efficient and cost-effective compared with blood-based tests, study findings published in Annals of Internal Medicine showed.

Adults may soon have an easy way to know whether they face a heightened risk for COPD and death due to a respiratory disease with the creation of a preclinical blood test that assesses 32 proteins, according to a press release.

A blood test to measure fibrinogen-to-albumin ratio predicted preeclampsia and severe preeclampsia risk in laboring women compared with other blood markers, potentially providing a useful tool for anesthesiologists, researchers reported.